Skip to main content

BRAF+ metastatic melanoma: from low burden of disease to brain metastases

By 14 Dicembre 2017Aprile 7th, 2021No Comments

We met Reinhard Dummer (Department of Dermatology, University Hospital Zurich) during the Symposium: “Bridge from adjuvant to metastatic melanoma: treating your BRAF+ patients with target therapy”, held at the Melanoma BRIDGE 2017 Congress, in Naples.